Terry Lo

Terry Lo is the President and CEO of Vizgen, which is developing and commercializing the next generation of genomics tools to expand on the capabilities of spatially resolved transcriptomics. Vizgen’s technology will aid the acceleration of biological research and discovery to advance human health.

Terry is a pioneer in the emerging Spatial Biology market and has a proven track record of driving exceptional growth across global life science organizations, including Bristol-Myers Squibb, Hologic, Roche, PerkinElmer, and Akoya Biosciences. In addition to over two decades of experience scaling and building multinational biopharma and diagnostic groups, he is also an expert in developing business strategies for novel, innovative products.